Genscript Biotech Corporation

SEHK:1548 Rapporto sulle azioni

Cap. di mercato: HK$22.7b

Genscript Biotech Salute del bilancio

Salute finanziaria criteri di controllo 4/6

Genscript Biotech ha un patrimonio netto totale di $1.8B e un debito totale di $877.2M, che porta il suo rapporto debito/patrimonio netto a 48.1%. Le sue attività totali e le sue passività totali sono rispettivamente $3.3B e $1.5B.

Informazioni chiave

48.1%

Rapporto debito/patrimonio netto

US$877.17m

Debito

Indice di copertura degli interessin/a
ContantiUS$1.88b
Patrimonio nettoUS$1.82b
Totale passivitàUS$1.51b
Totale attivitàUS$3.33b

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Market Still Lacking Some Conviction On Genscript Biotech Corporation (HKG:1548)

Nov 19
Market Still Lacking Some Conviction On Genscript Biotech Corporation (HKG:1548)

Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?

Oct 01
Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?

What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?

Sep 16
What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?

After Leaping 44% Genscript Biotech Corporation (HKG:1548) Shares Are Not Flying Under The Radar

Aug 02
After Leaping 44% Genscript Biotech Corporation (HKG:1548) Shares Are Not Flying Under The Radar

Slammed 28% Genscript Biotech Corporation (HKG:1548) Screens Well Here But There Might Be A Catch

Jun 05
Slammed 28% Genscript Biotech Corporation (HKG:1548) Screens Well Here But There Might Be A Catch

A Look At The Fair Value Of Genscript Biotech Corporation (HKG:1548)

May 10
A Look At The Fair Value Of Genscript Biotech Corporation (HKG:1548)

Is Genscript Biotech (HKG:1548) A Risky Investment?

Apr 13
Is Genscript Biotech (HKG:1548) A Risky Investment?

Investors Appear Satisfied With Genscript Biotech Corporation's (HKG:1548) Prospects As Shares Rocket 29%

Mar 13
Investors Appear Satisfied With Genscript Biotech Corporation's (HKG:1548) Prospects As Shares Rocket 29%

Genscript Biotech Corporation (HKG:1548) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jan 26
Genscript Biotech Corporation (HKG:1548) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Is Genscript Biotech (HKG:1548) A Risky Investment?

Nov 21
Is Genscript Biotech (HKG:1548) A Risky Investment?

Is Genscript Biotech (HKG:1548) A Risky Investment?

Aug 22
Is Genscript Biotech (HKG:1548) A Risky Investment?

Time To Worry? Analysts Just Downgraded Their Genscript Biotech Corporation (HKG:1548) Outlook

Apr 04
Time To Worry? Analysts Just Downgraded Their Genscript Biotech Corporation (HKG:1548) Outlook

Analysts Have Been Trimming Their Genscript Biotech Corporation (HKG:1548) Price Target After Its Latest Report

Apr 03
Analysts Have Been Trimming Their Genscript Biotech Corporation (HKG:1548) Price Target After Its Latest Report

Is Genscript Biotech (HKG:1548) A Risky Investment?

Apr 02
Is Genscript Biotech (HKG:1548) A Risky Investment?

Genscript Biotech Corporation (HKG:1548) Shares Could Be 25% Below Their Intrinsic Value Estimate

Feb 07
Genscript Biotech Corporation (HKG:1548) Shares Could Be 25% Below Their Intrinsic Value Estimate

What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?

Dec 14
What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?

Genscript Biotech Corporation (HKG:1548) Shares Could Be 22% Below Their Intrinsic Value Estimate

Nov 09
Genscript Biotech Corporation (HKG:1548) Shares Could Be 22% Below Their Intrinsic Value Estimate

Is Genscript Biotech (HKG:1548) Using Debt Sensibly?

Oct 22
Is Genscript Biotech (HKG:1548) Using Debt Sensibly?

Health Check: How Prudently Does Genscript Biotech (HKG:1548) Use Debt?

Apr 03
Health Check: How Prudently Does Genscript Biotech (HKG:1548) Use Debt?

Does Genscript Biotech (HKG:1548) Have A Healthy Balance Sheet?

Oct 03
Does Genscript Biotech (HKG:1548) Have A Healthy Balance Sheet?

Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?

Sep 07
Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?

Estimating The Fair Value Of Genscript Biotech Corporation (HKG:1548)

Aug 16
Estimating The Fair Value Of Genscript Biotech Corporation (HKG:1548)

Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?

Jun 03
Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?

Is Genscript Biotech Corporation (HKG:1548) Trading At A 49% Discount?

May 13
Is Genscript Biotech Corporation (HKG:1548) Trading At A 49% Discount?

Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?

Apr 16
Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?

Could The Genscript Biotech Corporation (HKG:1548) Ownership Structure Tell Us Something Useful?

Mar 20
Could The Genscript Biotech Corporation (HKG:1548) Ownership Structure Tell Us Something Useful?

Are Insiders Selling Genscript Biotech Corporation (HKG:1548) Stock?

Feb 13
Are Insiders Selling Genscript Biotech Corporation (HKG:1548) Stock?

Did The Underlying Business Drive Genscript Biotech's (HKG:1548) Lovely 753% Share Price Gain?

Jan 09
Did The Underlying Business Drive Genscript Biotech's (HKG:1548) Lovely 753% Share Price Gain?

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( $2.2B ) di 1548 superano le sue passività a breve termine ( $533.0M ).

Passività a lungo termine: Le attività a breve termine di 1548 ( $2.2B ) superano le sue passività a lungo termine ( $974.7M ).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: 1548 ha più liquidità del suo debito totale.

Riduzione del debito: Il rapporto debito/patrimonio netto di 1548 è aumentato da 4.2% a 48.1% negli ultimi 5 anni.


Bilancio


Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: 1548 ha una cash runway sufficiente per più di 3 anni in base al suo attuale free cash flow.

Previsione Cash Runway: Dati insufficienti per determinare se 1548 ha una sufficiente pista di cassa se il suo flusso di cassa libero continua a crescere o a ridursi in base ai tassi storici.


Scoprire le aziende sane